http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/
| My Groups | biotech-news Main Page | |
ASU Technopolis and TGen Team up for Second Life Sciences Forum
Focus on Financing and Investing for Life Science Researchers, Entrepreneurs and Investors
04-12-2006
ASU Technopolis and the Translational Genomics Research Institute (TGen) have once again joined forces to present the 2nd Annual Commercializing Arizona Life Sciences Forum on April 20 & 21 at the Phoenix Airport Marriott.
The Forum sessions are divided into two tracks, allowing investors/venture capitalists and researchers/entrepreneurs to receive information tailored to their respective needs. Confirmed keynote speakers include Dr. Fred Craves, co-founder and managing director, Bay City Capital; Dr. Kerry Dance, managing director, Hamilton Bioventures; Dr. Mark Ferguson, founder and CEO, Renovo of the United Kingdom; and Jack J. Florio, vice president, communications/board member of the San Diego Tech Coast Angels.
Registration is available online at www.asutechnopolis.org.
Session highlights for investors and venture capitalists, featuring keynote speaker presentations and panelists, include:
Session highlights for researchers and entrepreneurs, featuring keynote speaker presentations and panelists, include:
"The Annual Commercializing Arizona Life Sciences Forum is yet another opportunity for Arizona to advance innovations in the biosciences a critical sector that continues to garner much attention and interest from our state legislators and business leaders," remarked ASU President Michael Crow.
"This Forum provides a great opportunity to forge the critical connections between researchers, entrepreneurs, venture capitalists and investors that will catalyze commercialization," said Ellen Feigal, M.D., TGen deputy director of Clinical Sciences and director, Division of Molecular Imaging.
ASU Technopolis is the high impact and focused initiative of Arizona State University's President Michael Crow to move research in technology and the life sciences into the private sector and propel Greater Phoenix into the international economic arena as a viable player. A combination of targeted entrepreneurial education, coaching, and networking is producing results that will fuel business expansion, job growth, and greater prosperity for the people of Arizona. Through ASU Technopolis, entrepreneurs are connected to potential investors, board members, service providers, partners, customers, research and development collaborators, and other ASU units and programs.
ASU's Office of Economic Affairs (within the Office of the Vice President for Research and Economic Affairs) administers the ASU Technopolis program. Visit www.economicaffairs.org for more information.
The Translational Genomics Research Institute (TGen) is focused on developing earlier diagnostics and smarter treatments. Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases. TGen is focused on personalized medicine and plans to accomplish its goals through robust and disease-focused research. Visit TGen at www.tgen.org for more information.
###
MEDIA CONTACTS:
Karen Leland, [EMAIL PROTECTED]
480-965-4525
Office of Economic Affairs
Arizona State University
Amy K. Erickson, 602-343-8522
TGen
YAHOO! GROUPS LINKS
- Visit your group "biotech-news" on the web.
- To unsubscribe from this group, send an email to:
[EMAIL PROTECTED]
- Your use of Yahoo! Groups is subject to the Yahoo! Terms of Service.
